Federal Register Notice: CBER is inviting interested parties to participate in its Regulatory Site Visit Training Program intended to give CBER regulatory review, compliance, and other relevant staff an opportunity to visit biologics facilities. These visits allow CBER staff to directly observe routine manufacturing practices and to give staff a better understanding of the biologics industry. To view this notice, click here.
